X-Therma is headquartered in Hercules, CA along with its subsidiary location in Austria. X-Therma pioneers ground-breaking cold chain technology via a convergent bio-preservation platform, to advance the field of Regenerative Medicine and make available safe and on-demand engineered tissues, cell & gene therapies, vaccines, and beyond. X-Therma has been a selected Industrial User at the Lawrence Berkeley National Laboratory and received over $14M in contracts and grant support from the U.S. Department of Defense, the National Science Foundation, and the California Institute for Regenerative Medicine. The company recently closed an oversubscribed Series B funding round.
XT-Thrive® - Chemically Defined Safe & Effective Cryopreservation
XT-Thrive® proprietary cryopreservation media is intended for cryopreservation of cell and gene therapies for regenerative medicine applications in ultra-low temperature environments (-70° C to -196° C). The product is manufactured with USP/highest quality components and meets USP <71> Sterility and USP <85> Endotoxin testing standards. XT-Thrive® is available in GMP grade with DMF on file.